Biotron Limited (ASX: BIT)

Sector: Health Care

Market cap: A$6M (as of 2 Nov 2026)

Conduct clinical trials, research and commercialisation of a number of anti-viral (HCV and HIV) drugs developed from biomedical projects researched at the John Curtin School of Medical Research.

Data as of 2 Nov 2026.

Recent capital raises

Date	Type	Amount	Price	Discount	Source
30 Jan 2026	Rights issue	$1.524M	—	—	Filing ↗
19 Dec 2025	Rights issue	$0.646M	$0.00	—	Filing ↗
8 Apr 2025	Rights issue	$1.275M	$0.00	—	Filing ↗
21 Feb 2025	SPP	$2.707M	$0.01	—	Filing ↗
23 Nov 2022	Rights issue	$6M	—	—	Filing ↗

Substantial holders — latest moves

Date	Holder	Move	Holding	Source
18 Aug 2026	10 Bolivianos Pty Ltd and Freedom Trader Pty Ltd	Increase	9.35% → 10.01%	Filing ↗
12 Jan 2026	10 Bolivianos Pty Ltd and Freedom Trader Pty Ltd	Entry	?% → 9.350%	Filing ↗
19 Dec 2025	BERNE NO 132 NOMINEES PTY LTD	Entry	?% → 20.2%	Filing ↗

Cash and runway

Metric	Value	As of	Source
Cash	A$1M	30 Sept 2026	Filing ↗
Runway	2.2 quarters	30 Sept 2026	Filing ↗

Ask about BIT in Claude or ChatGPT

Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:

Has BIT raised money in the last year, and at what discount?
What was BIT's latest cash position and runway?

Setup guide for Claude, ChatGPT and other MCP clients →

Loading BIT…